A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

Clinical trial NCT05896371 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05896371
Sponsor: CHU de Quebec-Universite Laval
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Prostate Cancer Metastatic Cancer Metastatic Prostate Cancer

Start date: 2028-03-01
Primary completion: 2033-03-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.